Live Breaking News & Updates on Hims

Stay informed with the latest breaking news from Hims on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Hims and stay connected to the pulse of your community

Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells $34,916.85 in Stock

Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) insider Soleil Boughton sold 2,503 shares of the company’s stock in a transaction dated Monday, April 15th. The stock was sold at an average price of $13.95, for a total transaction of $34,916.85. Following the completion of the sale, the insider now directly owns 164,363 […]

United-kingdom , United-states , Leerink-partnrs , Soleil-boughton , Piper-sandler , Hims-hers-health-inc , Belpointe-asset-management , Hims-hers-health-company-profile , Harbour-investments-inc , Hims-hers-health , Institutional-trading-of-hims-hers-health , Cm-wealth-advisors

5,500 Shares in Hims & Hers Health, Inc. (NYSE:HIMS) Acquired by FNY Investment Advisers LLC

FNY Investment Advisers LLC bought a new position in Hims & Hers Health, Inc. (NYSE:HIMS – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 5,500 shares of the company’s stock, valued at approximately $48,000. Several other hedge funds and other institutional investors […]

United-kingdom , Blackrock , United-kingdom-general- , United-states , Andrew-dudum , Soleil-boughton , Leerink-partnrs , Hims-hers-health-company-profile , Fny-investment-advisers , Citigroup , Hims-hers-health-inc , News-ratings-for-hims-hers-health-daily

Hims & Hers Health (NYSE:HIMS) Rating Reiterated by Leerink Partnrs

Hims & Hers Health (NYSE:HIMS – Get Free Report)‘s stock had its “market perform” rating reissued by investment analysts at Leerink Partnrs in a research report issued on Monday, PriceTargets.com reports. Leerink Partnrs also issued estimates for Hims & Hers Health’s FY2026 earnings at $0.23 EPS. HIMS has been the topic of several other research […]

Oluyemi-okupe , Andrew-dudum , Leerink-partnrs , Analyst-recommendations-for-hims-hers-health , Cm-wealth-advisors , Harbour-investments-inc , Hims-hers-health-company-profile , Hims-hers-health-trading , Hims-hers-health , Belpointe-asset-management , Hims-hers-health-inc , News-ratings-for-hims-hers-health-daily

Hims & Hers Health's (HIMS) "Market Perform" Rating Reaffirmed at Leerink Partnrs

Hims & Hers Health (NYSE:HIMS – Get Free Report)‘s stock had its “market perform” rating reissued by investment analysts at Leerink Partnrs in a research report issued on Monday, PriceTargets.com reports. Leerink Partnrs also issued estimates for Hims & Hers Health’s FY2026 earnings at $0.23 EPS. Several other equities analysts also recently commented on the […]

Leerink-partnrs , Andrew-dudum , Soleil-boughton , Hims-hers-health-stock-performance , Forerunner-ventures-management , News-ratings-for-hims-hers-health-daily , Hims-hers-health-inc , Hims-hers-health , Millennium-management , Samlyn-capital , Analyst-recommendations-for-hims-hers-health , Marshall-wace

Algert Global LLC Increases Stock Position in Hims & Hers Health, Inc. (NYSE:HIMS)

Algert Global LLC boosted its stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS – Free Report) by 22.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 187,550 shares of the company’s stock after buying an additional 33,960 shares during the […]

Oluyemi-okupe , Piper-sandler , Leerink-partnrs , Soleil-boughton , Hsbc-holdings , Hermes-inc , Quarter-for-hims-hers-health , Hims-hers-health-stock , Northern-trust-corp , Hims-hers-health-profile , Hims-hers-health-inc , Hims-hers-health

Telehealth company Hims & Hers' stock jumps on hopes of a first profitable year

Shares of Hims & Hers Health Inc. rallied after hours on Monday, after the online wellness platform said 2024 would be its first year of positive net...

Hims-hers-health-inc , Hers-health , Article-normal , Pharmaceuticals , Machinery , Agricultural-machinery , Retail-wholesale , Pharmacies-drugstores , Specialty-retailing , Health-care , Industrial-goods

Workday, Zoom Video, Unity Software, CarGurus, Coinbase, Lowe's, and More Market Movers

Workday shares fall after earnings, Zoom Video jumps after posting a profit beat on strong enterprise growth, Unity Software tumbles after its forecast...

Federal-reserve , York-stock-exchange-photo , Wall-street , New-york-stock-exchange , Getty-images , Article-normal , Computers-consumer-electronics , Software , Applications-software , Food-beverages , Dairy-products

Hims & Hers Health, Inc. (NYSE:HIMS) Receives Consensus Rating of "Moderate Buy" from Analysts

Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) has been given an average rating of “Moderate Buy” by the ten brokerages that are currently covering the stock, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The […]

Soleil-boughton , Irene-becklund , Coppell-advisory-solutions , Cm-wealth-advisors , Hims-hers-health-stock-performance , Hims-hers-health , Analyst-recommendations-for-hims-hers-health , Hims-hers-health-company-profile , News-ratings-for-hims-hers-health-daily , Hims-hers-health-inc , Securities-exchange-commission , Belpointe-asset-management

Truist Financial Boosts Hims & Hers Health (NYSE:HIMS) Price Target to $13.00

Hims & Hers Health (NYSE:HIMS – Get Free Report) had its target price hoisted by analysts at Truist Financial from $10.00 to $13.00 in a note issued to investors on Tuesday, Benzinga reports. The firm presently has a “hold” rating on the stock. Truist Financial’s target price indicates a potential upside of 26.58% from the […]

Irene-becklund , Oluyemi-okupe , Leerink-partnrs , News-ratings-for-hims-hers-health-daily , Hims-hers-health-inc , Hims-hers-health-trading , Hims-hers-health , Cm-wealth-advisors , Analyst-recommendations-for-hims-hers-health , Belpointe-asset-management , Harbour-investments-inc , Securities-exchange-commission

Hims & Hers Health (NYSE:HIMS) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS

Hims & Hers Health (NYSE:HIMS – Get Free Report) issued its quarterly earnings data on Monday. The company reported $0.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.03, Briefing.com reports. Hims & Hers Health had a negative return on equity of 11.22% and a negative net margin of […]

Soleil-boughton , Andrew-dudum , Leerink-partnrs , Marshall-wace , Hims-hers-health-inc , Dimensional-fund-advisors , Samlyn-capital , News-ratings-for-hims-hers-health-daily , Hims-hers-health , Earnings-history-for-hims-hers-health , Millennium-management , Hims-hers-health-trading